InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by 권영이, 董事长兼首席执行官. Insider active across 2 companies, notably 삼익제약. Aggregated, 6 disclosures have been published. History available since 26 March 2026. The latest transaction was filed on 27 May 2026 (Sale). Regulator: DART (FSS). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Kwon Young-hee is the chairman and CEO of Samik Pharmaceutical. In this role, he is responsible for the strategic and operational direction of the company. Samik Pharmaceutical specializes in the pharmaceutical sector. Kwon Young-hee plays a crucial role in guiding and growing the company.